Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-010721

Chief Executive Officer gave up 7,172 shares (to pay taxes)

  • Chief Executive Officer acquired 24,474 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2024-03-31 Option exercise +24,474 173,302.8 D: show line 1 in the form
Robinson Chandler Chief Executive Officer 2024-03-31 Shares withheld for taxes −7,172 $0.68 $4,884 166,130.8 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2024-03-31 Option exercise · Restricted Stock Units −24,474 197,811 D: show line 3 in the form
Loading xslF345X05/rdgdoc.xml…